Wednesday, November 5, 2025
HomeNews

News

Ada Health Receives EU-MDR Certification for AI-Powered Symptom Assessment Platform

Ada Health GmbH ('Ada Health') the global digital health company focused on improving human health at scale, announces that Ada Assess has successfully been...

Solve Therapeutics Announces Mission to Advance Novel Antibody-Based Therapies Against Cancer-Specific Targets

Solve Therapeutics, Inc., an oncology-focused biopharmaceutical company, announced its mission to develop novel antibody-based therapies targeting tumor-specific antigens. The company's formation reunites the former...

Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major...

Dupixent Approved by European Commission as the First and Only Targeted Medicine

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European Union to...

Cambium Networks Delivers Industry’s First 6 GHz Full Spectrum Fixed Wireless Broadband

Cambium Networks, a leading global provider of networking solutions, introduced the ePMP 4600, a next-generation fixed wireless platform that lets service providers and private...
0FansLike
0FollowersFollow
spot_img

Hot Topics